Skip to content
Back to Blog
Government Programs
2026-03-3012 min read66

Complete Guide to 2026 Global Collaborative R&D Program: Application Strategies for Preliminary and Open-Call Tracks

The Korean Ministry of SMEs has announced the 2026 Global Collaborative R&D Program with two tracks. Learn about the elimination of product restrictions and updated application strategies.

KITIM Consulting Team

Overview of the 2026 Global Collaborative R&D Program

The Korean Ministry of SMEs and Startups has announced the 2026 Global Collaborative R&D Support Program, a new initiative designed to help domestic SMEs and mid-sized enterprises strengthen their global market entry capabilities through joint research with overseas institutions and companies.

The most significant change is the complete elimination of the previous 124-item product restriction. Companies can now freely propose their own research topics, dramatically expanding participation opportunities across diverse technology sectors.

Key Dates

  • Announcement: March 23, 2026
  • Application Period: April 6-24, 2026
  • Program Types: Preliminary Research Track, Open-Call Track (2 tracks)
  • Detailed Comparison of Two Tracks

    Preliminary Research Track

    The Preliminary Research Track is ideal for companies that have not yet secured overseas collaboration partners or wish to validate the feasibility of joint research before committing to a full-scale project.

  • Funding: Up to approximately KRW 100 million per project
  • Duration: 6 months to 1 year
  • Key Activities: Partner discovery, joint research planning, preliminary technology validation, market research
  • Target Companies: Early-stage companies with limited global R&D experience
  • Open-Call Track

    The Open-Call Track is for companies that have already established concrete joint research plans with overseas partner institutions.

  • Funding: Up to approximately KRW 500 million per project (varies by year)
  • Duration: 2-3 years
  • Key Activities: Joint technology development, prototype production, overseas certification/standards compliance, global market testing
  • Target Companies: Companies with confirmed overseas partners and concrete commercialization plans
  • What the Elimination of Product Restrictions Means

    Previously, the Global Collaborative R&D program only accepted applications in 124 government-designated product categories. With the complete removal starting in 2026, AI, bio-healthcare, ESG, and other emerging technology companies can now participate freely.

    Eligibility and Application Strategy

    Basic Qualifications

  • Classified as an SME or mid-sized enterprise under Korean law
  • At least 1 year since corporate establishment
  • Research personnel in the relevant technology field
  • Step-by-Step Application Strategy

  • Track Selection (D-30): Assess global collaboration readiness
  • Business Plan Core Structure (D-20): Technical differentiation, collaboration necessity, market analysis
  • Overseas Partner Agreement (D-15): Secure partner documentation and IP terms
  • Final Document Review (D-5): Completeness check and online submission test
  • How KITIM Can Help

    KITIM specializes in government R&D project planning and proposal writing. We support Global Collaborative R&D applications through track selection consulting, proposal writing services, partner agreement advisory, presentation coaching, and post-selection support.

    The application deadline of April 24 is approaching fast. Contact KITIM for a free consultation today.

    Global R&DKorean SMEsInternational CollaborationR&D FundingGovernment Support2026 ProgramsMarket Expansion

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.